Hong Kong

Hong Kong, a key international business hub, is the latest addition to the worldwide CMS locations. Opened in September 2016, the Hong Kong office is the anchor point for companies from Germany and Europe (including Russia) with business interests in China and the South-East Asia/Pacific region. Equally, Chinese and Asian firms operating abroad, or intending to do so, will find the right advisors at CMS in Hong Kong. Particularly noteworthy is the role of Hong Kong as a centre for international arbitration and dispute resolution, in addition to international business transactions. Accordingly, our team in Hong Kong advises primarily on international arbitration and alternative dispute resolution and on corporate/M&A matters.

The team of experienced lawyers awaiting you in Hong Kong has been supporting clients locally in international arbitration proceedings and advising on their business operations in the region for many years. What sets our practice in Hong Kong apart is that CMS is the first major law firm with roots in civil law to become established in Hong Kong, a traditional common law jurisdiction. Chinese, European, Russian and Asian clients alike can thus all rely on CMS for insightful advice. Our services are tailored to the local requirements in Hong Kong and also to the needs of international clients by CMS lawyers who have been trained in both legal cultures.

Please do not hesitate to contact our lawyers in Hong Kong – we will be glad to answer your questions.

more less


The Hong Kong office is located in Central Hong Kong on Hong Kong Island. You can access the office from the main entrance located at the corner of Queen’s Road Central and Ice House Street.

From the Airport
Distance from the airport is approx 30KM. A taxi or the Airport Express is the most efficient way of reaching the office. When taking the Airport Express you will arrive at Hong Kong Station. From here you are able to get a taxi the short distance to the office. Alternatively the office is within walking distance. You will need to walk to Central Station via the underground walkway. From here take Exit G on Pedder Street. From here the office is a short walk.

When taking the MTR you will need to take the Island Line or Tsuen Wan Line to Central Station. From here take Exit G on Pedder Street. From here the office is a short walk.

more less


CMS Hasche Sigle, Hong Kong LLP
27/F, 8 Queen´s Road Central
Hong Kong
Hong Kong


Show only
October 2017
CMS - Where to find us
CMS Chile # 1 in TTR - Trans­ac­tion­al Track Re­cord rank­ing year to...
IP in the Cloud: the China Per­spect­ive
China is in the middle of a rap­id shift to­wards cloud tech­no­lo­gies. Ex­e­cu­tion of the 13th Five Year Plan will de­liv­er sub­stan­tial in­vest­ment in­to cloud com­put­ing and the sec­tor is un­der­go­ing un­pre­ced­en­ted growth.
August 2017
CMS - Facts & Fig­ures
Wuhan In­ter­me­di­ate People’s Court re­cog­nises a US court judg­ment –...
In an un­pre­ced­en­ted move, the Wuhan In­ter­me­di­ate People’s Court (the “Wuhan Court”) de­livered a judg­ment re­cog­nising and en­for­cing a United States com­mer­cial judg­ment. The judg­ment, de­livered on 30 June 2017, sig­nals an im­port­ant shift in Chinese ju­di­cial at­ti­tude.
July 2017
Your in­tro­duc­tion to CMS
Please join us in Lon­don for a day of in­ter­est­ing pan­el dis­cus­sions...
New clin­ic­al tri­al re­gime will sub­stan­tially speed up drug re­gis­tra­tion...
After re­ceiv­ing com­ments on the draft of the De­cision of the State Ad­min­is­tra­tion of Food and Drug Ad­min­is­tra­tion on Ad­just­ing the Rel­ev­ant Is­sues Con­cern­ing the Re­gis­tra­tion and Ad­min­is­tra­tion of Im­por­ted Drugs (the “De­cision”) in March 2017, the China Food.
September 2017
CMS Hongkong
Sig­ni­fic­ant re­form to en­cour­age the in­nov­a­tion of drugs and med­ic­al...
Fol­low­ing the pub­lic­a­tion of vari­ous draft pro­pos­als to stim­u­late in­nov­a­tion of drugs and med­ic­al devices by the China Food and Drug Ad­min­is­tra­tion (“CF­DA”) in May, the State Coun­cil fi­nally pub­lished the "Opin­ions on Deep­en­ing Reg­u­lat­ory Re­forms to En­cour­age.
October 2016
In­vest­ment Pro­tec­tion in Asia-Pa­cific
In­sight in­to our Train­ing Ses­sion in Cam­bod­ia
We are de­lighted to in­vite you to the Au­tumn We­bin­ar Series hos­ted...
CF­DA cla­ri­fies the reg­u­lat­ory re­gime on on­line drug trad­ing
Fol­low­ing the is­su­ance of “De­cision on Can­cel­ling An­oth­er Batch of Ad­min­is­trat­ive Ap­prov­al Items” by the State Coun­cil which can­celled the ap­prov­al re­quire­ments for en­ter­prises which provide third party on­line drug trad­ing ser­vices, the China Food and Drug.
CMS opens of­fice in Hong Kong
China Lifes­ci­ences Monthly Up­date - Au­gust & Septem­ber 2017
Draft new rules for ad­vert­ise­ments of med­ic­al products, 29 Septem­ber The State Ad­min­is­tra­tion for In­dustry and Com­merce (“SAIC”) is­sued the Stand­ards for Cen­sor­ing and Launch­ing Ad­vert­ise­ments of Drugs, Med­ic­al Devices, Di­et­ary Sup­ple­ments and Foods for Spe­cial.